Axial Capital Partners
Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Early Stage, Series A, Series B, Growth, Pre-IPO, Buyout
Geographical Focus
United States, United Kingdom, Canada, Germany, Australia, Europe, France, Italy, Denmark, Switzerland, Spain, Ireland, Austria, Netherlands, Hungary, Sweden, Belgium, Norway, Finland, Poland, Czech Republic
Industries Focus
- Financial Services
- Technology
- Healthcare
- Energy
- Consumer Goods
- Real Estate
- Telecommunications
- Media
- Retail
- Education
- Agriculture
- FinTech
- Logistics
- Transportation
- Hospitality
- Manufacturing
- AgriTech
- Medtech
- Biotechnology
- Ecommerce
- IP-driven Platforms
Investment Size:
50,000 to 1,000,000 USD
Investor Details Founded: 2015
Axial Capital Partners is a private equity firm investing in early-stage companies across various sectors, including biotechnology and life sciences. They focus on businesses that demonstrate low capital expenditure models with recurring B2B revenue streams, aiming to enhance value by leveraging their established presence across the UK, North America, Australia, and Europe. Their investment approach emphasizes capital efficiency and seeks founders who exhibit this approach from the outset.
The firm operates a corporate finance team that leads on more complex transactions, including buy-out and expansion advisory, as well as capital raising and exit solutions for both their portfolio and larger clients. They typically syndicate venture rounds with other investors, leveraging their established presence across core operating regions to accelerate revenue growth and technology development. Axial Capital Partners is sector agnostic in their approach, investing resources and growth capital into businesses that can demonstrate proven revenue generation and a viable market.
Over the past decade, Axial Capital Partners has been involved in leading investment for growth-stage startups and managing corporate buy & build and cross-border investment deals with transaction values into the tens of millions. Beyond initial financing, they sit in advisory board positions where appropriate and commit further resources as each portfolio company achieves new milestones or enters new markets, aiming for sustained, long-term value for all stakeholders.
Requirements
- Proven market fit
- Recurring revenue streams
- Scalable business models
- Strong management teams
- Innovative technology solutions
- Proven revenue generation
- Viable market
- Capital efficiency
- Low capital expenditure models
- Recurring B2B revenue streams
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- MedTech Ventures
- CloudSaaS Solutions
- AgriTech Innovations
- FinTech Enterprises
- eCommerce Platforms
- Appia Bio
- Seranova Bio
- Simcha Therapeutics
- Enable Medicine
- Delix Therapeutics
- Aperiam Bio
- Think Bioscience
- BigHat Biosciences
Mentioned In
-
$24.95
-
$19.95
-
$19.95
-
$49.95
-
$24.95
-
$19.95
-
$99.00
Claim this Investor
Are you an official representative of Axial Capital Partners?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim